An Important Genetic Screen for Men with Advanced Prostate Cancer – The Tamoxifen Test – Clearing CYP2D6

Whenever we take a drug, whether it's in injectable or an oral drug it must be cleared from our bodies otherwise it can become toxic to us. Unfortunately, our ability to clear drugs varies from individual to individual. These different abilities are often related to genetic differences we each have from one another. Doing of [...]

Researchers Find Consistent Epigenetic ‘Signatures’ In Prostate Cancer Patients’ Who Have Metastases

Scientists at the Johns Hopkins Kimmel Cancer Center found in a genome-wide analysis of 13 men with metastatic prostate cancer that there were consistent epigenetic "signatures" or “marks” across all metastatic tumors in each of the subject men. The discovery contradicts the current belief that epigenetic marks that sit on the nuclear DNA of cancer [...]

By |2017-10-19T10:50:13-04:00January 28th, 2013|Advanced Prostate Cancer, Research,